Leidos reported $1.3 billion in revenues for the third quarter of 2015, up 2 percent from $1.28 billion in the third quarter of 2015.
MedAssets‘ stock has a price target of $39.60 per share after hitting a new 52-week high, according to a Financial Magazin report.
McKesson posted a 10 percent growth in revenue for the second quarter of 2016, but gross profit dipped from $2.86 million last year to $2.84 million this year.
Mediware Information Systems, a post-acute care software company, expanded its denial management solutions offerings through its partnership with ZirMed.
If you have a question, issue or note to suggest on revenue cycle management company, please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on finance issues:
Cleveland Clinic vs. Mayo Clinic: 5 key comparisons, 2 amazing institutions
House approves budget deal that includes payment cuts to HOPDs
RCM tip of the day: Use comparative metrics
